[Event Report] The Second Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) (March 19, 2020)
date : 5/27/2020
Tags: AMR
Nikkei Inc. and AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) jointly held the Second Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC).
Working groups (WG) were established under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) in order to discuss the state of the antimicrobial market.
At this second meeting of WG1, WG1 members discussed the definition and categorization of pull incentives.
On the basis of WG discussions, participants agreed to join the second sub-committee on AMR and continue to work hard toward the eventual formulation of a concrete proposal on ways to incentivize antimicrobial R&D in the future.
In light of the situation with novel coronavirus, this meeting was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.
■Overview
Date and time: Thursday, March 19, 2020
Organizer: AMR Alliance Japan (Secretariat: HGPI)
■Discussion
WG1 Members (alphabetical order by last name):
Yusuke Ariyoshi (Director, Healthcare Policy, Government Affairs Dept., Shionogi & Co., Ltd.)
Masashi Kawata (Senior Manager, Public Affairs & Policy, Corporate Affairs, Health & Value, Pfizer Japan Inc.)
Tatsuro Kuzuki (Scientific Liaison, DNDi Japan)
Shoji Miyagawa (Director, Division of Infectious Disease Research, The Japan Agency for Medical Research and Development (AMED))
Akio Ozaki (Director, Public and Industry Policy, Health Policy, MSD K. K.)
Yosuke Sugiyama (Manager, Trade Associations & Regional Support, Global Public Affairs, Corporate Communications & Public Affairs, Takeda Pharmaceutical Company Limited)
Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)
Moderator:
Joji Sugawara (AMR Alliance Japan Secretariat/Senior Associate, HGPI)
Secretariat (alphabetical order by last name):
Matt McEnany (AMR Alliance Japan Secretariat/Manager, HGPI)
Tomohito Shibata (AMR Alliance Japan Secretariat/Senior Associate, HGPI)
Chiaki Toma (The Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) Project, Nikkei Inc.)
Mio Wakasa (The Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) Project, Nikkei Inc.)
■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)
January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Discussion Points] NCDs-related Cross-project “Lessons and Challenges Drawn from NCDs Responses in Local Governments and Future Visions” (June 17, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Policy Recommendations] Suggestions for Building a Resilient and Greener Health Care System Considering Sustainability and Environmental Concerns in the Revision of Medical, Nursing Care, and Disability Welfare Service Fees (December 6, 2023)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2024-08-27
[Registration Open] (Webinar) HGPI Special Seminar Commemorating Dementia Month and World Alzheimer’s Month “Examining the Role of Industry in Creating a Dementia-Inclusive Society” (September 19, 2024)
-
2024-08-28
[Research Paper] HGPI Planetary Health Project’s Research on the Knowledge, Attitudes, and Practices of Japanese Physicians Relating to Climate Change and Health published in the Journal of Public Health (July 15, 2024)
-
2024-09-02
[Registration Open] An Online Seminar on Stress Management to Mark World Mental Health Day 2024 (October 2, 2024)
-
2024-09-11
[Survey Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Preliminary Version) (September 11, 2024)